Combining The Power of Protein Degraders With The Precision of Antibodies for Synergistic Potential Using Degrader-Antibody Conjugates (DACs)
Time: 8:30 am
day: Scientific Program Day Two AM
Details:
- Delving into the mechanism and design of an antibody degrader conjugate, considering aspects like linker design for stability and efficient PROTAC release
- Evaluating safety, pharmacokinetic, pharmacodynamic and anti-tumor activity data
- Discussing the rationale for the chosen format and value proposition over traditional approaches
